Hampton et al estimate the numbers and rates of adverse drug event emergency department visits involving psychiatric medications among US adults between 2009 and 2011. Medical records from national probability samples were reviewed and analyzed. Exposures were antidepressants, antipsychotics, lithium salts, sedatives and anxiolytics, and stimulants.
This population epidemiology study uses data from the US Centers for Disease Control and Prevention to compare trends and patterns of mortality from self-injury with those from diabetes, influenza and pneumonia, and kidney disease between 1999 and 2014.
This population epidemiology study of patients with schizophrenia uses Medicaid data to compare overall and cause-specific mortality rates for adults with schizophrenia vs the US general population between 2001 and 2007.
This randomized clinical trial examines whether d-cycloserine augments cognitive behavioral therapy in the treatment of obsessive-compulsive disorder (OCD) and whether concomitant use of antidepressants moderates the effects of d-cycloserine.
This randomized, double-blind, parallel-group, forced-dose titration, placebo-controlled clinical trial demonstrates efficacy for the 50- and 70-mg/d dosages of lisdexamfetamine dimesylate compared with placebo for treatment of binge-eating disorder.